In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aton Pharma Inc.

Division of Bausch Health Companies Inc.
www.atonrx.com

Latest From Aton Pharma Inc.

Valeant Backs Strategy With Solid Deal Record

Reiterating the strength of its M&A-heavy strategy, Valeant CEO Michael Pearson touted the company's deal record during its second quarter earnings call.

BioPharmaceutical North America

Hi-Tech Deal Broadens Akorn Consumer Business

Akorn’s $650 million acquisition of Hi-Tech Pharmacal provides a potential long-term platform for Rx-to-OTC switches and offers additional OTC cross-selling opportunities with retailers. Akorn CEO Raj Rai calls the transaction a “transformative event” that will be instantly accretive for the firm.

Consumer Strategy

Hi-Tech Deal Broadens Akorn Consumer Business

Akorn’s $650 million acquisition of Hi-Tech Pharmacal provides a potential long-term platform for Rx-to-OTC switches and offers additional OTC cross-selling opportunities with retailers. Akorn CEO Raj Rai calls the transaction a “transformative event” that will be instantly accretive for the firm.

Consumer Strategy

Ophthalmology M&A Engine Keeps Roaring As Akorn Buys Out Hi-Tech

CEO Raj Rai calls the transaction a “transformative event” for Akorn that will be instantly accretive and produce between $15 million and $20 million of run-rate synergies within 12 months. Acquisition of Hi-Tech adds prescription and OTC products, 18 filed ANDAs and increased manufacturing capability.

Consumer BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bausch Health Companies Inc.
  • Senior Management
  • Michael G Wells, Pres. & CEO
    George J Parise, CFO
    Wayne S Mulcahy, PhD, VP, Clin. Ops.
    Barry L Levinson, PhD, VP, Bus. Dev.
  • Contact Info
  • Aton Pharma Inc.
    Phone: (609) 671-9010
    3150 Brunswick Pike
    Ste. 230
    Lawrenceville, NJ 08648
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register